Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stock

Showing results (241-250 of 322) with videos related to

Pageof 33
Sort By:
Blood Advances|July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)Alison R Walker, Guido Marcucci, Jun Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Blood Advances|June 12, 2023
A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central AmericaJuan Rangel-Patiño, Yu Ling Lee-Tsai, Victor Itaí Urbalejo-Ceniceros, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Blood Advances|January 4, 2018
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLLSabah Kadri, Jimmy Lee, Carrie Fitzpatrick, et al.
Leukemia|February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance studyKrzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Cancer|December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaGail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyZachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Bio-Protocol|August 14, 2023
Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia CellsLauren Rowland, Brandon Smart, Anthony Brown, et al.
Pageof 33

Showing results (241-250 of 322) with videos related to

Sort By:
Pageof 33
Blood Advances|July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)Alison R Walker, Guido Marcucci, Jun Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Blood Advances|June 12, 2023
A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central AmericaJuan Rangel-Patiño, Yu Ling Lee-Tsai, Victor Itaí Urbalejo-Ceniceros, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Blood Advances|January 4, 2018
Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLLSabah Kadri, Jimmy Lee, Carrie Fitzpatrick, et al.
Leukemia|February 24, 2023
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance studyKrzysztof Mrózek, Jessica Kohlschmidt, James S Blachly, et al.
Haematologica|January 15, 2026
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemiaIvy E Abraham, Garth H Rauscher, Jerry Luo, et al.
Cancer|December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemiaGail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyZachariah DeFilipp, Anjali S Advani, Veronika Bachanova, et al.
Bio-Protocol|August 14, 2023
Ex vivo Drug Sensitivity Imaging-based Platform for Primary Acute Lymphoblastic Leukemia CellsLauren Rowland, Brandon Smart, Anthony Brown, et al.
Pageof 33